PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Emergency Medicine, University of Pittsburgh School of Medicine, 606B Scaife Hall, Pittsburgh, PA, 15213, USA. huangdt@upmc.edu.\', \'Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. huangdt@upmc.edu.\', \'Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.\', \'Department of Emergency Medicine, University of Pittsburgh School of Medicine, 606B Scaife Hall, Pittsburgh, PA, 15213, USA.\', \'Clinical Analytics, UPMC, Pittsburgh, PA, USA.\', \'Wolff Center, UPMC, Pittsburgh, PA, USA.\', \'Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.\', \'UPMC Health System Office of Healthcare Innovation, Pittsburgh, PA, USA.\', \'Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.\', \'Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.\', \'Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.\', \'Berry Consultants, Austin, TX, USA.\', \'Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.\', \'UPMC Health Services Division, Pittsburgh, PA, USA.\', \'UPMC Supply Chain Management/HC Pharmacy, Pittsburgh, PA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05316-3
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34034784
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all